Order Article Reprints

Capone E, Lamolinara A, Pastorino F, Gentile R, Ponziani S, Di Vittorio G, D’Agostino D, Bibbò S, Rossi C, Piccolo E, et al. Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers. 2020; 12(10):2989. https://doi.org/10.3390/cancers12102989

Capone, Emily, Alessia Lamolinara, Fabio Pastorino, Roberta Gentile, Sara Ponziani, Giulia Di Vittorio, Daniela D’Agostino, Sandra Bibbò, Cosmo Rossi, Enza Piccolo, and et al. 2020. "Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma" Cancers 12, no. 10: 2989. https://doi.org/10.3390/cancers12102989

Capone, E., Lamolinara, A., Pastorino, F., Gentile, R., Ponziani, S., Di Vittorio, G., D’Agostino, D., Bibbò, S., Rossi, C., Piccolo, E., Iacobelli, V., Lattanzio, R., Panella, V., Sallese, M., De Laurenzi, V., Giansanti, F., Sala, A., Iezzi, M., Ponzoni, M., ... Sala, G. (2020). Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma. Cancers, 12(10), 2989. https://doi.org/10.3390/cancers12102989